Gemcitabine Improves Suppressive Immune Microenvironment Induced by Long-Term Treatment with EGFR-TKIs: Implications for Combination Chemotherapy and Immunotherapy
机构：[1]Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan/CN,四川大学华西医院[2]Department of Oncology, Sichuan Cancer Hospital, Chengdu, Sichuan/CN四川省肿瘤医院
第一作者机构：[1]Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan/CN,
推荐引用方式(GB/T 7714)：
Wu X.,Tang J.,Liu X.,et al.Gemcitabine Improves Suppressive Immune Microenvironment Induced by Long-Term Treatment with EGFR-TKIs: Implications for Combination Chemotherapy and Immunotherapy[J].JOURNAL OF THORACIC ONCOLOGY.2020,15(2):S25-S25.
APA：
Wu, X.,Tang, J.,Liu, X.,Ma, Q.,Shu, P....&Wang, Y..(2020).Gemcitabine Improves Suppressive Immune Microenvironment Induced by Long-Term Treatment with EGFR-TKIs: Implications for Combination Chemotherapy and Immunotherapy.JOURNAL OF THORACIC ONCOLOGY,15,(2)
MLA：
Wu, X.,et al."Gemcitabine Improves Suppressive Immune Microenvironment Induced by Long-Term Treatment with EGFR-TKIs: Implications for Combination Chemotherapy and Immunotherapy".JOURNAL OF THORACIC ONCOLOGY 15..2(2020):S25-S25
医学